Schmidt Eric Thomas is Chief Financial Officer of Allogene Therapeutics Inc.
Person profile
Roles
Allogene Therapeutics
Chief Financial Officer
Revolution Medicines
Director
Relmada Therapeutics
Director
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Revolution Medicines, Inc.
12 Jun 23
4
RELMADA THERAPEUTICS, INC.
30 May 23
4
Allogene Therapeutics, Inc.
24 Mar 23
4
Allogene Therapeutics, Inc.
16 Mar 23
4
RELMADA THERAPEUTICS, INC.
20 Dec 22
4
Revolution Medicines, Inc.
17 Jun 22
4
RELMADA THERAPEUTICS, INC.
26 May 22
4
Allogene Therapeutics, Inc.
25 Mar 22
4
Allogene Therapeutics, Inc.
17 Mar 22
4
RELMADA THERAPEUTICS, INC.
21 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jun 23 | RVMD Revolution Medicines | Common Stock | Grant | Acquire A | No | No | 0 | 5,200 | 0.00 | 21,251 |
8 Jun 23 | RVMD Revolution Medicines | Stock Option Common Stock | Grant | Acquire A | No | No | 24.84 | 18,400 | 457.06 k | 18,400 |
25 May 23 | RLMD Relmada Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.37 | 92,958 | 313.27 k | 150,000 |
22 Mar 23 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 558,094 | 0.00 | 862,439 |
22 Mar 23 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.04 | 432,738 | 2.18 mm | 432,738 |
14 Mar 23 | ALLO Allogene Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 5.47 | 35,879 | 196.26 k | 304,345 |
16 Dec 22 | RLMD Relmada Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.37 | 57,042 | 192.23 k | 57,042 |